Risk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP

Project: Research

Participants

Colleges, School and Institutes

Short titleRisk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP
StatusActive
Effective start/end date1/12/1530/11/20